Darmstadt, Germany

Ronald Keiner

This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: Merck Patent Gmbh. Active years: 2011.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Ronald Keiner. Retrieved from https://idiyas.com/inventor/ronald-keiner

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile



Average Co-Inventor Count = 5.0

ph-index = 1

Forward Citations = 9(Granted Patents)


Company Filing History:


Years Active: 2011

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovations of Ronald Keiner

Introduction

Ronald Keiner is a notable inventor based in Darmstadt, Germany. He has made significant contributions to the field of pharmaceuticals through his innovative work. His expertise and dedication have led to the development of unique compounds that hold promise for medical applications.

Latest Patents

Keiner holds a patent for a novel crystal form of (3-cyano-1H-indol-7-yl)-[4-(4-fluorophenethyl)-piperazin-1-yl]methanone, hydrochloride. This invention relates to a previously unknown crystal form B of the compound, along with a process for its preparation. The potential uses of this compound include its application in the development of medicaments, showcasing Keiner's impact on pharmaceutical innovation.

Career Highlights

Keiner is currently associated with Merck Patent GmbH, where he continues to push the boundaries of pharmaceutical research. His work has not only contributed to the company's portfolio but has also advanced the field of medicinal chemistry.

Collaborations

Throughout his career, Keiner has collaborated with esteemed colleagues such as Andreas Bathe and Bernd Helfert. These partnerships have fostered a collaborative environment that enhances the innovation process.

Conclusion

Ronald Keiner's contributions to the field of pharmaceuticals through his patent and collaborations highlight his role as a significant inventor. His work continues to influence the development of new medicaments, showcasing the importance of innovation in healthcare.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…